10 April 2026
At the Eye Center of New York, clinical precision and forward-thinking care define the patient experience. Led by Dr. Tal Raviv, MD, FACS, an internationally recognized authority in cataract and refractive surgery, the practice applies that same level of rigor to pediatric eye care through Dr. Lisabeth S. Hall, MD. A fellowship-trained pediatric ophthalmologist with over 25 years of experience and former Director of Pediatric Ophthalmology and Strabismus at New York Eye and Ear Infirmary, Dr. Hall focuses specifically on early myopia management to protect long-term visual health.
Myopia control should begin as soon as nearsightedness is identified, often between ages 5 and 6. This is when the eye is growing most rapidly, making early intervention significantly more effective at slowing progression. Here is a closer look at why timing matters and how early treatment changes outcomes.
Why Early Myopia Control Matters
Myopia is a progressive condition driven by elongation of the eye. As that elongation increases, so does the lifetime risk of structural complications that can impact vision.
Early intervention allows treatment to influence eye growth while it is still actively changing. This is where myopia control has the greatest impact, shifting the focus from simply updating prescriptions to actively slowing progression.
Key risks associated with higher levels of myopia include:
- Retinal detachment risk: Increased eye length places mechanical stress on the retina over time.
- Myopic maculopathy: Ongoing elongation can lead to degenerative changes affecting central vision.
- Glaucoma and early cataracts: Higher levels of myopia are associated with earlier onset of these conditions.
What Drives Myopia Progression in Children
The rise in childhood myopia reflects a combination of environmental exposure and visual habits. These influences compound over time, accelerating the pace of prescription changes.
Common contributing factors include:
- Increased near work: Sustained focus at close distances from reading and screen use places continuous demand on the eyes.
- Reduced outdoor exposure: Natural light helps regulate normal eye development.
- Earlier academic intensity: Increased visual demands at younger ages may contribute to earlier onset and faster progression.
These factors are not always avoidable, which is why structured treatment plays an important role alongside practical lifestyle adjustments.
Myopia Control Options at Eye Center of New York
Dr. Lisabeth S. Hall, MD, develops individualized treatment strategies based on a detailed evaluation of each child’s age, progression pattern, and daily routine. The goal is to select an approach that is both clinically effective and realistically sustainable.
Available treatment options include:
- Essilor Stellest lenses: Advanced spectacle lenses that use highly aspherical lenslet technology to slow eye elongation while functioning like standard glasses.
- Low-dose atropine drops: A nightly therapy that helps modulate the biological signals linked to excessive eye growth, with a strong safety profile at low concentrations.
- MiSight contact lenses: Daily disposable lenses designed specifically for children, offering both vision correction and clinically validated myopia control.
- Combination therapy: In cases of faster progression, combining treatments can enhance overall effectiveness.
Treatment selection is guided by measurable clinical factors rather than preference alone, ensuring each plan is tailored with precision.
Take a Proactive Approach to Your Child’s Vision
Families who choose our practice benefit from unhurried consultations, precise measurements, and treatment plans built around each child’s needs, all within a refined, thoughtfully designed environment that prioritizes comfort and clarity at every step.
Schedule a consultation with the Eye Center of New York to receive a comprehensive myopia evaluation and a personalized plan grounded in expertise, precision, and long-term vision protection.
